ScoreWhy is Anuh Pharma Ltd ?
1
Poor long term growth as Net Sales has grown by an annual rate of 13.69% and Operating profit at 7.18% over the last 5 years
2
Negative results in Sep 25
- PBT LESS OI(Q) At Rs 8.94 cr has Fallen at -29.3% (vs previous 4Q average)
- PAT(Latest six months) At Rs 15.91 cr has Grown at -35.19%
- ROCE(HY) Lowest at 15.90%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
No Data Found
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
13.69%
EBIT Growth (5y)
7.18%
EBIT to Interest (avg)
42.53
Debt to EBITDA (avg)
0.36
Net Debt to Equity (avg)
-0.04
Sales to Capital Employed (avg)
2.06
Tax Ratio
24.70%
Dividend Payout Ratio
15.87%
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
19.97%
ROE (avg)
14.83%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
21
Industry P/E
34
Price to Book Value
2.53
EV to EBIT
17.98
EV to EBITDA
14.64
EV to Capital Employed
2.59
EV to Sales
1.12
PEG Ratio
NA
Dividend Yield
1.82%
ROCE (Latest)
14.43%
ROE (Latest)
11.84%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend4What is working for the Company
NET SALES(Latest six months)
At Rs 372.36 cr has Grown at 22.54%
-14What is not working for the Company
PBT LESS OI(Q)
At Rs 8.94 cr has Fallen at -29.3% (vs previous 4Q average
PAT(Latest six months)
At Rs 15.91 cr has Grown at -35.19%
ROCE(HY)
Lowest at 15.90%
DPS(Y)
Lowest at Rs 0.75
DPR(Y)
Lowest at 15.87%
CASH AND CASH EQUIVALENTS(HY)
Lowest at Rs 2.15 cr
EPS(Q)
Lowest at Rs 0.76
Loading Valuation Snapshot...
Here's what is working for Anuh Pharma
Net Sales - Latest six months
At Rs 372.36 cr has Grown at 22.54%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Here's what is not working for Anuh Pharma
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 8.94 cr has Fallen at -29.3% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 12.64 CrMOJO Watch
Near term PBT trend is very negative
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Latest six months
At Rs 15.91 cr has Grown at -35.19%
Year on Year (YoY)MOJO Watch
Near term PAT trend is negative
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Lowest at Rs 0.76
in the last five quartersMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (Rs)
Cash and Cash Equivalents - Half Yearly
Lowest at Rs 2.15 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Dividend per Share (DPS) - Annually
Lowest at Rs 0.75
in the last five yearsMOJO Watch
Company is distributing lower dividend than previous years
DPS (Rs)
Dividend Payout Ratio (DPR) - Annually
Lowest at 15.87%
in the last five yearsMOJO Watch
Company is distributing lower proportion of profits generated as dividend
DPR (%)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
